MCRB - Seres Therapeutics, Inc.
IEX Last Trade
0.9509
0 0%
Share volume: 44
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$0.95
0.00
0.00%
Summary score
25%
Profitability
18%
Dept financing
25%
Liquidity
46%
Performance
27%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.63%
Return on assets
-11.79%
Return on sales
-6151.05%
Return on invested capital
-48.92%
Total debt ratio
86.45%
Debt ratio change over timeo
-1.44%
Current Ratio
3.31%
Quick Ratio
3.25%
Cash Position Ratio
3.06%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
170.36%
Return on assets
-5.83%
Return on sales
-27550.22%
Return on invested capital
-26.21%
Total debt ratio
107.14%
Debt ratio change over timeo
-2.16%
Current Ratio
2.35%
Quick Ratio
2.09%
Cash Position Ratio
1.88%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
67.18%
Return on assets
-11.6%
Return on sales
0%
Return on invested capital
-51.72%
Total debt ratio
117.51%
Debt ratio change over time
-3.41%
Current Ratio
1.68%
Quick Ratio
1.25%
Cash Position Ratio
1.13%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-114.1%
Return on assets
-93.44%
Return on sales
9447.33%
Return on invested capital
99.88%
Total debt ratio
-144.22%
Debt ratio change over time
-1.44%
Current Ratio
-2.17%
Quick Ratio
-2.07%
Cash Position Ratio
-1.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MCRB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.63% | 13.79% | 34.47% | 7.43% |
| Return on assets | -11.79% | 2.76% | 3.15% | 5.62% |
| Return on sales | -6151.05% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -48.92% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 86.45% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.44% | 308.97% | -6.99% | 1.18% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 2.35% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.09% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 65% | 13% | 29% | 67% |
| Short-term ratios | MCRB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 170.36% | 13.77% | 13.25% | 3.8% |
| Return on assets | -5.83% | 2.43% | 1.89% | 3.09% |
| Return on sales | -27550.22% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -26.21% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 48% | 46% | 76% |
| Total debt ratio | 107.14% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.16% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 46% | 22% | 6% |
| Current Ratio | 2.35% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.09% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 38% | 12% | 31% | 75% |